Tatva Chintan Pharma Chem Limited is an India-based specialty chemical manufacturing company. The Company is engaged in the manufacturing of a variety of chemicals, including structure directing agents (SDAs), phase transfer catalysts (PTCs), electrolyte salts and solutions (ESS) for capacitor batteries, and pharmaceutical and agrochemical intermediates, and other specialty chemicals (PASC). Its SDAs are used for forming channels in zeolites. Its PTCs are used in heterogeneous multiphase systems, facilitating reactant migration. It operates through the Specialty chemical segment. The Company operates two manufacturing facilities situated at Ankleshwar and Dahej in Bharuch, Gujarat, India. It caters to various customers across various industries, including the automotive, refinery, pharmaceutical, agrochemicals, paints and coatings, dyes and pigments, personal care, and flavors and fragrances industries. The Company’s subsidiaries are Tatva Chintan Europe B.V. and Tatva Chintan USA Inc.As of 25 May 2026, Tatva Chintan Pharma Chem share price is ₹1,182.70. The stock opened at ₹1,187.50, compared to its previous close of ₹1,187.50. During today's trading session, Tatva Chintan Pharma Chem share price moved in the range of ₹1,176.00 to ₹1,208.10, with an average price of ₹1,192.05 for the day. Looking at its last 52-week, the stock has touched a low of ₹1,176.00 and a high of ₹1,208.10. On the performance front, Tatva Chintan Pharma Chem share price has declined by 19.28% over the last six months and is up 27.70% on a year-on-year basis.
The market capitalization of Tatva Chintan Pharma Chem is ₹2,779 Crs, with a P/E ratio of 66.1 and a dividend yield of 0.00%.